Abstract
Insulinoma is uncommon endocrine tumors that have a prevalence of around 1 per 100,000 person-years. However; they represent the most common functioning endocrine tumor of the pancreas and is the main cause for hypoglycemia due to endogenous hyperinsulinism. In the presence of significant financial constraints in the patient population pancreatic insulinoma's management is difficult. In last 20 years development in diagnosis and surgery minimize complications.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Annals of oncology : official journal of the European Society for Medical Oncology
Paper Title
Journal
Date
